Retrospective analysis of perioperative ketorolac and postoperative bleeding in reduction mammoplasty

Canadian Journal of Anesthesia

Volumn 59, Issue 5, 2012, Pages 466-472

  Cawthorn, Thomas R ^a   Phelan, Rachel ^b   Davidson, John S ^b   Turner, Kim E ^a,b  

^a QUEEN S UNIVERSITY   (Canada)

^b KINGSTON GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

KETOROLAC;

ADULT; BLOOD TRANSFUSION; BREAST REDUCTION; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMOGRAPHY; DRUG UTILIZATION; FEMALE; HEMATOMA; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; PERIOPERATIVE PERIOD; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PAIN; PRIORITY JOURNAL; REOPERATION; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SINGLE DRUG DOSE; SURGEON;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; FEMALE; HEMATOMA; HUMANS; INJECTIONS, INTRAVENOUS; KETOROLAC; MAMMAPLASTY; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; RETROSPECTIVE STUDIES;

EID: 84862761876     PISSN: 0832610X     EISSN: 14968975     Source Type: Journal    
DOI: 10.1007/s12630-012-9682-z     Document Type: Review

References (17)

1. Gillis JC, Brogden RN. Ketorolac. A reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic use in pain management. Drugs 1997; 53: 139-88. (Pubitemid 27045700)
2. Gillies GW, Kenny GN, Bullingham RE, McArdle CS. The morphine sparing effect of ketorolac tromethamine. A study of a new, parenteral non-steroidal anti-inflammatory agent after abdominal surgery. Anaesthesia 1987; 42: 727-31.
3. O'Hara DA, Fragen RJ, Kinzer M, Pemberton D. Ketorolac tromethamine as compared with morphine sulfate for treatment of postoperative pain. Clin Pharmacol Ther 1987; 41: 556-61. (Pubitemid 17074332)
4. Sinha VR, Kumar RV, Singh G. Ketorolac tromethamine formulations: an overview. Expert Opin Drug Deliv 2009; 6: 961-75.
5. Pichard CP, Laporte DM. Use of ketorolac (toradol) in hand surgery. J Hand Surg Am 2009; 34: 1549-50.
6. Reinhart DI. Minimising the adverse effects of ketorolac. Drug Saf 2000; 22: 487-97.
7. Bauer KA, Gerson W, Wright C 4th, et al. Platelet function following administration of a novel formulation of intravenous diclofenac sodium versus active comparators: a randomized, single dose, crossover study in healthy male volunteers. J Clin Anesth 2010; 22: 510-8.
8. Garcha IS, Bostwick J. Postoperative hematomas associated with Toradol. Plast Reconstr Surg 1991; 88: 919-20.
9. Blomqvist L, Sellman G, Strombeck JO. NSAID as pre- and postoperative medication - a potential risk for bleeding complications in reduction mammaplasty. Eur J Plast Surg 1996; 19: 26-8. (Pubitemid 26051231)
10. Shapiro DS, Loiacono LA. Mean arterial pressure: therapeutic goals and pharmacologic support. Crit Care Clin 2010; 26: 285-93.
11. Sharma S, Chang DW, Koutz C, et al. Incidence of hematoma associated with ketorolac after TRAM flap breast reconstruction. Plast Reconstr Surg 2001; 107: 352-5. (Pubitemid 32125276)
12. Agrawal A, Gerson CR, Seligman I, Dsida RM. Postoperative hemorrhage after tonsillectomy: use of ketorolac tromethamine. Otolaryngol Head Neck Surg 1999; 120: 335-9. (Pubitemid 29135866)
13. Chin KR, Sundram H, Marcotte P. Bleeding risk with ketorolac after lumbar microdiscectomy. J Spinal Disord Tech 2007; 20: 123-6. (Pubitemid 46588322)
14. Vitale MG, Choe JC, Hwang MW, et al. Use of ketorolac tromethamine in children undergoing scoliosis surgery: an analysis of complications. Spine J 2003; 3: 55-62. (Pubitemid 38351773)
15. RuDusky BM. Severe postoperative hemorrhage attributed to single-dose parenteral ketorolac-induced coagulopathy. Angiology 2000; 51: 999-1002.
16. Judkins JH, Dray TG, Hubbell RN. Intraoperative ketorolac and posttonsillectomy bleeding. Arch Otolaryngol Head Neck Surg 1996; 122: 937-40. (Pubitemid 26304229)
17. Splinter WM, Rhine EJ, Roberts DW, Reid CW, MacNeill HB. Preoperative ketorolac increases bleeding after tonsillectomy in children. Can J Anaesth 1996; 43: 560-3. (Pubitemid 26291281)